UBS Maintains Buy on Omega Healthcare Invts, Raises Price Target to $54

Benzinga Newsdesk www.benzinga.com Positive 77.8%

Neg 0% Neu 0% Pos 77.8%

UBS analyst Michael Goldsmith maintains Omega Healthcare Invts (NYSE:OHI) with a Buy and raises the price target from $52 to $54.